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Regional roadmaps for reducing premature deaths from NCDs
In September, 2011, a high-level meeting of the UN 
called for a concerted global response to the growing 
challenge of non-communicable diseases (NCDs).1 
Subsequently, in 2013, the World Health Assembly 
adopted a WHO-generated action plan and set a target 
of 25 × 25: a 25% reduction in premature mortality 
from four major NCDs (deaths in the age group of 
30–70 years) by 2025, when compared with a baseline 
of 2010. The mortality target was linked to six targets 
for control of major risk factors and two targets for 
improving coverage with, and access to, essential drugs.2
Can the world achieve this aspirational mortality 
target in the face of advancing NCD epidemics in low-
income and middle-income countries? Aﬃ  rmation 
came from a modelling study by Kontis and colleagues3 
who estimated that achieving the six risk-factor-related 
targets would take us close to the mortality target, and 
it could be fully accomplished by adopting an aggressive 
approach to tobacco control (to achieve 50% reduction 
in prevalence of global tobacco consumption, moving 
beyond the 30% target set by WHO).
An extension of that study by Kontis and colleagues, 
published in The Lancet Global Health,4 proﬁ les the likely 
changes in premature NCD-related mortality, modelling 
both the anticipated secular trends and the potential 
added eﬀ ect of six risk factor reduction strategies in each 
of the six regional groupings of WHO member countries. 
The study ﬁ nds that, without any new intervention, 
proportional rates of premature mortality from NCDs 
would show a secular decline in all regions other than 
Africa, which would experience a rise. However, the 
cumulative eﬀ ect of this decline would fall well short of 
the global 25 × 25 target.
Eﬀ ective actions for achieving the six risk-factor-
related targets can move all regions, except Africa, close 
to the target of 25% reduction in premature mortality, 
according to Kontis and colleagues. Europe, with low 
levels of premature mortality and a 20·3% projected 
secular decline, will surpass the target, whereas 
four other regions will fall slightly short. With more 
aggressive tobacco control, they too can breach the 
25% mark. Africa remains the exception because the 
rise of NCDs will aﬀ ect a relatively young population 
and the presently low level of tobacco consumption will 
restrict the eﬀ ect of tobacco control. The need for Africa 
to focus on other NCD risk factors, especially those of 
infectious aetiology, was emphasised in an earlier call for 
a revised target.5
The wide range of premature mortality across regions 
can be explained by diﬀ ering stages of epidemiological 
transition.6,7 Europe has high life expectancy and the 
burden of NCD deaths mostly occurs at older ages. Africa 
is in the earlier stages of epidemiological transition, 
with the burdens of NCD mortality mostly distributed 
at younger ages. Other regions are midway through 
health transition and have high burdens of premature 
mortality despite declining secular trends. Even within 
regions, countries vary widely in their positions across 
the transition pathway. 
Regional and sex variations in the eﬀ ect of diﬀ erent 
risk factors expectedly emerge from the modelling. 
Control of high blood pressure yields greater beneﬁ t 
than tobacco control in women, whereas the order is 
reversed in men. Tobacco control can have a profound 
eﬀ ect in the western Paciﬁ c region (with high levels 
of smoking in China), whereas blood pressure is the 
major risk factor to target in Africa. Because the model 
only considers cigarette smoking, the eﬀ ect of tobacco 
control would have been underestimated for southeast 
Asia, in which oral tobacco consumption is widespread 
in countries like India. The limitations of focusing 
only on four NCDs are evident when alcohol control 
appears relatively unimportant, despite the many other 
health eﬀ ects that make alcohol a major contributor to 
premature mortality.
Although the study provides useful roadmaps 
for regional prioritisation of action on NCD risk 
factors to buttress policymaker conﬁ dence that the 
25 × 25 target is within reach, regional analyses have 
restricted relevance for national policies. The highly 
heterogeneous nature of most WHO regional groups 
neither assures similarity of health and developmental 
proﬁ les nor ensures geographical proximity within 
each region. WHO’s western Paciﬁ c regional grouping 
provides a striking example of this wide scatter. Political 
considerations too have aﬀ ected regional allocations, 
with South Korea grouped in the western Paciﬁ c 
region and North Korea in the southeast Asian region. 
Similarly, Israel is in the European region, whereas 
Syria and Egypt are with the eastern Mediterranean 
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region. How will Sudan and Qatar, with vastly diﬀ erent 
resources, implement common regional plans for NCD 
risk factor prevention and control within the eastern 
Mediterranean region? Although the targets set by 
WHO are applicable to all countries, national strategies 
for implementation will be substantially aﬀ ected by the 
local context and country-speciﬁ c data.
The 25 × 25 target will soon be subsumed by the 
Sustainable Development Goal on health, which sets an 
upgraded target of one-third reduction in premature 
mortality due to NCDs between 2015 and 2030.8 
Nevertheless, the thrust provided by intervention 
impact modelling for the 2025 target must propel 
global health to the farther target.
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